From the Carleton Newsroom…
MPs mum about possibility of national drug plan
Parliamentary health committee reviews draft pharmacare report in closed-door meeting
By Vik Adhopia, CBC News Posted: Feb 02, 2018 4:34 PM ET Last Updated: Feb 05, 2018 10:35 AM ET
“It’s completely dysfunctional,” said Marc-André Gagnon, a professor of health and pharmaceutical policy at Carleton University in Ottawa, who was called as an expert witness by the parliamentary committee.
Gagnon said because there are multiple drug buyers in the country, including hospitals, provinces and the private system, it’s led to several middlemen, needless price mark-ups and overall higher prices.
“For me, this doesn’t make any sense. This is money that should not be taken out of the health-care system.”